Tracleer

Actelion's Opsumit growth heralds smooth switch off aging Tracleer
Fierce Pharma
Tue, 07/21/15 - 10:34 am
Actelion
Opsumit
Tracleer
PAH
pulmonary arterial hypertension
The top 10 patent losses of 2015
Fierce Pharma
Fri, 12/19/14 - 08:35 am
patents
Lantus
Abilify
Copaxone
Neulasta
Tracleer
Namenda
Avodart
Jalyn
Zyvox
Androgel
Synagis
Sanofi
Bristol-Myers Squibb
Otsuka
Teva Pharmaceutical
Amgen
Actelion
Actavis
GSK
Pfizer
AbbVie
AstraZeneca
Actelion Raises Full-Year Profit Forecast on Opsumit
Bloomberg
Tue, 07/22/14 - 08:58 am
Actelion
Opsumit
Tracleer
earnings
Phase 4 Actelion Study Misses Primary Endpoint
Forbes
Mon, 03/17/14 - 04:58 pm
Actelion
Tracleer
pulmonary arterial hypertension
Actelion gets second boost for Opsumit with EU approval
Fierce Pharma
Mon, 12/23/13 - 03:23 pm
Actelion
Opsumit
Europe
Tracleer
PAH
pulmonary arterial hypertension
FTC slams drugmaker for withholding samples
Pharmalot
Wed, 03/13/13 - 10:47 am
samples
generics
Actelion
Tracleer
Roxane Laboratories
Apotex
Actelion Looks Within as Competition Lifts Drug Prices
Bloomberg
Mon, 02/18/13 - 12:24 pm
Actelion
pulmonary arterial hypertension
PAH
Tracleer
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Mon, 10/22/12 - 12:09 pm
Bayer
PAH
Actelion
Gilead
Riociguat
Tracleer
Actelion Expects Tracleer Competition, Has Quarterly Loss
Bloomberg
Thu, 07/21/11 - 12:26 pm
earnings
Tracleer
Actelion
Actelion Enters Evel Knievel Territory
WSJ Online
Mon, 01/31/11 - 11:51 am
Actelion
Tracleer
PAH
FDA Slams Actelion Amid BMS Buyout Rumors
Motley Fool
Thu, 10/7/10 - 06:03 pm
Bristol-Myers Squibb
FDA
Actelion
M&A
Tracleer
Ventavis
Actelion Pharma Failed To Report 3,500 Deaths
Pharmalot
Thu, 10/7/10 - 11:49 am
Actelion
FDA
adverse events
Tracleer
Ventavis
FDA Warns Actelion Unit On Post-Marketing Drug Report Failures
WSJ Online
Tue, 10/5/10 - 11:12 am
FDA
Actelion
post-marketing data
Tracleer
Ventavis
PAH